Cost-Utility Study of PCV13 Versus PPSV23 in Adults in Chile.
Sign Up to like & getrecommendations! Published in 2018 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2018.09.005
Abstract: INTRODUCTION Pneumococcal infections are a public health problem in older adults. In Chile there are two vaccines at this time, PPSV23 and PCV13. The first has lower immunogenicity and effectiveness in preventing pneumococcal pneumonia and… read more here.
Keywords: ppsv23; ppsv23 adults; pcv13 versus; versus ppsv23 ... See more keywords
Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
Sign Up to like & getrecommendations! Published in 2022 at "Pathogens"
DOI: 10.3390/pathogens12050732
Abstract: The 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) were previously recommended for adults in the United States. To help inform discussions on recently licensed 15- and 20-valent pneumococcal vaccine use among… read more here.
Keywords: pneumococcal pneumonia; ppsv23; pcv13; efficacy effectiveness ... See more keywords